Manelimab

Tax included
Manelimab is a monoclonal antibody that inhibits programmed death-ligand 1 (PD-L1).
MedChemExpress 
HY-P99723

Data sheet

Size
Multiple sizes
Reactivity
PD-1/PD-L1
Application
Cancer-programmed cell death
CAS
2168561-26-8